Antioxidants and Therapeutic Targets in Ovarian Clear Cell Carcinoma

Ovarian clear cell carcinomas (OCCCs) are resistant to conventional anti-cancer drugs; moreover, the prognoses of advanced or recurrent patients are extremely poor. OCCCs often arise from endometriosis associated with strong oxidative stress. Of note, the stress involved in OCCCs can be divided into...

Full description

Saved in:
Bibliographic Details
Published inAntioxidants Vol. 10; no. 2; p. 187
Main Authors Amano, Tsukuru, Murakami, Atsushi, Murakami, Takashi, Chano, Tokuhiro
Format Journal Article
LanguageEnglish
Published Switzerland MDPI AG 28.01.2021
MDPI
Subjects
antioxidant
Antioxidants
Antitumor agents
Apoptosis
cancer stemness
Cancer therapies
Carcinogenesis
Carotenoids
Cell cycle
Chemotherapy
Deoxyribonucleic acid
DNA
DNA damage
Drug development
Endometriosis
Estrogens
Experiments
Flavonoids
Inflammation
Iron
Metabolism
Metabolites
Mutation
Ovarian cancer
Ovarian carcinoma
ovarian clear cell carcinoma
Oxidants
Oxidative stress
Population
Prevention
Reactive oxygen species
Review
Transcription
Tumors
United States > US
Japan
endometriosis
ovarian clear cell carcinoma
antioxidant
cancer stemness
Online AccessGet full text

Cover

More Information
Summary:Ovarian clear cell carcinomas (OCCCs) are resistant to conventional anti-cancer drugs; moreover, the prognoses of advanced or recurrent patients are extremely poor. OCCCs often arise from endometriosis associated with strong oxidative stress. Of note, the stress involved in OCCCs can be divided into the following two categories: (a) carcinogenesis from endometriosis to OCCC and (b) factors related to treatment after carcinogenesis. Antioxidants can reduce the risk of OCCC formation by quenching reactive oxygen species (ROS); however, the oxidant stress-tolerant properties assist in the survival of OCCC cells when the malignant transformation has already occurred. Moreover, the acquisition of oxidative stress resistance is also involved in the cancer stemness of OCCC. This review summarizes the recent advances in the process and prevention of carcinogenesis, the characteristic nature of tumors, and the treatment of post-refractory OCCCs, which are highly linked to oxidative stress. Although therapeutic approaches should still be improved against OCCCs, multi-combinatorial treatments including nucleic acid-based drugs directed to the transcriptional profile of each OCCC are expected to improve the outcomes of patients.
ISSN:2076-3921
2076-3921
DOI:10.3390/antiox10020187